Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2020 09:00 ET | Source: GeoVax, Inc.

GeoVax Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial

Company Comments on NIH/NIAID Discontinuance of Sanofi/GSK HVTN 702 Trial ATLANTA, GA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology...
December 02, 2019 09:00 ET | Source: GeoVax, Inc.

GeoVax Observes 2019 World AIDS Day

Developing Multiple Strategies Toward Ending the HIV/AIDS Epidemic ATLANTA, GA, Dec. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company...
July 24, 2019 09:00 ET | Source: GeoVax, Inc.

GeoVax Presents HIV Vaccine Study Data

Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
February 06, 2019 10:11 ET | Source: GeoVax, Inc.

GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message

Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX)....
December 03, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Observes 2018 World AIDS Day

Recognizing the Importance of Partnerships ATLANTA, GA, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE– GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
November 28, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Provides Update on HIV Clinical Trials Program

Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
October 24, 2018 11:00 ET | Source: GeoVax, Inc.

GeoVax Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference

Booster Vaccination After ~7 Years Resulted in 600-fold Increase in Antibody Response ATLANTA, GA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
October 22, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Announces Publication of HIV Vaccines Review

Comprehensive Review Published in the Peer-Reviewed Journal, Clinical Pharmacology and Therapeutics ATLANTA, GA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...
September 27, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Observes National Gay Men’s HIV/AIDS Awareness Day

ATLANTA, GA, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Gay Men’s HIV/AIDS...
May 21, 2015 11:31 ET | Source: International Centre for Infectious Disease

HIV Vaccine Awareness Day Recognizes Global Efforts

WINNIPEG, May 21, 2015 (GLOBE NEWSWIRE) -- Recent scientific discoveries in HIV illustrate the need for partnerships and collaboration in the effort to develop a safe and effective HIV vaccine. But...